Search research articles
Contact Us
Filters
Showing results (121-130 of 184) with videos related to
Page
of 19
Sort By:
Tropical Medicine & International Health : TM & IH
|
July 2, 2020
Willingness to use HIV self-test kits and willingness to pay among urban antenatal clients in Cote d'Ivoire and Tanzania: a cross-sectional study
Kim Ashburn, Gretchen Antelman, Marc Kouadio N'Goran, et al.
Microbiology Spectrum
|
June 9, 2025
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2
Andy Kwan Pui Chan, San Suwanmanee, Arturo Casadevall, et al.
BMJ Open
|
May 1, 2024
Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol
Karen Birkenhead, David Sullivan, Claire Trumble, et al.
Prostate Cancer and Prostatic Diseases
|
May 5, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Tahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, et al.
Journal of Visualized Experiments : Jove
|
March 15, 2012
Large-scale recording of neurons by movable silicon probes in behaving rodents
Marie Vandecasteele, S M, Sébastien Royer, et al.
Journal of the American Heart Association
|
February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study
Malcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Biomedical Optics Express
|
October 25, 2019
Aberration-free multi-plane imaging of neural activity from the mammalian brain using a fast-switching liquid crystal spatial light modulator
Rui Liu, Neil Ball, James Brockill, et al.
Circulation
|
November 21, 2013
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial
Michael J Koren, Robert P Giugliano, Frederick J Raal, et al.
Journal of the American College of Cardiology
|
April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab
Erik Stroes, David Colquhoun, David Sullivan, et al.
International Journal of Cardiology
|
March 12, 2014
Associations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians
Kostas Kapellas, Lisa M Jamieson, Loc G Do, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 184) with videos related to
Sort By:
Page
of 19
Tropical Medicine & International Health : TM & IH
|
July 2, 2020
Willingness to use HIV self-test kits and willingness to pay among urban antenatal clients in Cote d'Ivoire and Tanzania: a cross-sectional study
Kim Ashburn, Gretchen Antelman, Marc Kouadio N'Goran, et al.
Microbiology Spectrum
|
June 9, 2025
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2
Andy Kwan Pui Chan, San Suwanmanee, Arturo Casadevall, et al.
BMJ Open
|
May 1, 2024
Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol
Karen Birkenhead, David Sullivan, Claire Trumble, et al.
Prostate Cancer and Prostatic Diseases
|
May 5, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Tahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, et al.
Journal of Visualized Experiments : Jove
|
March 15, 2012
Large-scale recording of neurons by movable silicon probes in behaving rodents
Marie Vandecasteele, S M, Sébastien Royer, et al.
Journal of the American Heart Association
|
February 18, 2022
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study
Malcolm West, Adrienne Kirby, Ralph A Stewart, et al.
Biomedical Optics Express
|
October 25, 2019
Aberration-free multi-plane imaging of neural activity from the mammalian brain using a fast-switching liquid crystal spatial light modulator
Rui Liu, Neil Ball, James Brockill, et al.
Circulation
|
November 21, 2013
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial
Michael J Koren, Robert P Giugliano, Frederick J Raal, et al.
Journal of the American College of Cardiology
|
April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab
Erik Stroes, David Colquhoun, David Sullivan, et al.
International Journal of Cardiology
|
March 12, 2014
Associations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians
Kostas Kapellas, Lisa M Jamieson, Loc G Do, et al.
Page
of 19